Valuation: Evotec SE

Market Cap 498M 567M 468M 428M 799M 54.32B 805M 5.62B 2.18B 27.69B 2.13B 2.08B 89.79B P/E 2026 *
-2.39x
P/E 2027 * -6.51x
Enterprise Value 641M 730M 602M 550M 1.03B 69.91B 1.04B 7.23B 2.8B 35.64B 2.74B 2.68B 116B EV / Sales 2026 *
1.07x
EV / Sales 2027 * 0.91x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day-0.46%
1 week-3.02%
Current month-13.89%
1 month-14.63%
3 months-41.89%
6 months-32.14%
Current year-48.72%
1 week 2.73
Extreme 2.734
3.1
1 month 2.73
Extreme 2.734
3.41
Current year 2.73
Extreme 2.734
6.73
1 year 2.73
Extreme 2.734
7.3
3 years 2.73
Extreme 2.734
21.69
5 years 2.73
Extreme 2.734
45.47
10 years 2.73
Extreme 2.734
45.83
Manager TitleAgeSince
Chief Executive Officer 55 2024-06-30
Director of Finance/CFO - 2026-04-30
Chief Operating Officer - 2026-04-30
Director TitleAgeSince
Director/Board Member 58 2019-06-18
Director/Board Member 64 2021-05-31
Director/Board Member 59 2024-06-09
Date Insider Type Main position Quantity % Market Cap. Importance
5/20/26 Exercice

Chief Technology Officer

12,462 0.0070%
5/4/26 Buy 15,510 0.0087%
5/4/26 Buy

Head of Human Resources

15,228 0.0086%
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%-3.02%-55.12%-85.39% 567M
+0.61%+3.34%+7.36%+30.34% 47.56B
-0.83%-0.36%+43.66%+34.77% 44.09B
-0.84%+4.86%+10.92%+91.52% 41.5B
-1.10%-2.64%+331.49%+535.80% 40.88B
-0.62%+0.11%+1.12%+46.02% 29.67B
-2.07%+0.12%+24.39%+154.30% 17.23B
+0.53%-0.34%+23.78%+39.97% 15.06B
-6.08%-9.92% - - 14.65B
-0.78%+9.46%-8.96% - 13.82B
Average -1.05%+0.59%+42.07%+105.92% 26.5B
Weighted average by Cap. -0.71%+0.96%+67.65%+140.58%

Financials

2026 *2027 *
Net sales 601M 685M 565M 516M 965M 65.58B 972M 6.78B 2.63B 33.44B 2.57B 2.51B 108B 724M 825M 681M 622M 1.16B 79.03B 1.17B 8.18B 3.17B 40.29B 3.1B 3.03B 131B
Net income -202M -230M -190M -174M -324M -22.05B -327M -2.28B -884M -11.24B -864M -845M -36.44B -48.25M -54.97M -45.36M -41.47M -77.49M -5.27B -78.06M -545M -211M -2.68B -206M -202M -8.7B
Net Debt 143M 163M 134M 123M 229M 15.59B 231M 1.61B 625M 7.95B 611M 598M 25.77B 162M 185M 152M 139M 260M 17.7B 262M 1.83B 710M 9.02B 694M 679M 29.26B
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,461
Date Price Change Volume
26-09-24 2.802 +0.07% 24,516
26-09-23 €2.800 -0.21% 792,148
26-09-22 €2.806 +0.43% 1,366,933
26-09-21 €2.794 -4.12% 1,397,572
26-09-18 €2.914 +1.11% 1,694,608
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
2.800EUR
Average target price
4.586EUR
Spread / Average Target
+63.78%

Quarterly revenue - Rate of surprise